$3.00
-0.02 (-0.66%)
Vical, Inc. (VICL)
CAPS Rating:
The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

RSS Headlines
Fool UK